Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Digest Bermuda.
Press releases published on July 14, 2025
Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
GlobeNewswire
·
July 14, 2025
July 14, 2025 Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a …
Disc Medicine Appoints Nadim Ahmed to its Board of Directors
GlobeNewswire
·
July 14, 2025
WATERTOWN, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …
Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard
GlobeNewswire
·
July 14, 2025
HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on July 10, 2025 the Company received notification from The Nasdaq Stock Market LLC (Nasdaq) of an additional extension to …
Endless Developer Grant Program Concludes First Stage, Crowns StarAI, Funmeta, and VDEP as Tier 1 Winners
GlobeNewswire
·
July 14, 2025
London, UK, July 14, 2025 (GLOBE NEWSWIRE) -- At the Brunel Hack 25 - Blockchain Hackathon …
Full Alliance Group Launches Qubitera Holdings, to Develop Quant Blockchain and YAHBEE Wallet for Healthcare and Web3
GlobeNewswire
·
July 14, 2025
TAMPA, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group Inc. (OTC: FAGI) today announced the formation of Qubitera Holdings, Inc., a majority-owned subsidiary (80% ownership), created to lead the development of decentralized infrastructure and …
Real World Data Supports Results of Route 92 Medical’s SUMMIT MAX Clinical Trial
GlobeNewswire
·
July 14, 2025
SAN MATEO, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced results from an independent, real- …
Recludix Pharma Announces Strengthening of Leadership Team, Including Promotion of Dr. Brian Hodous to Chief Scientific Officer
GlobeNewswire
·
July 14, 2025
--Brian Hodous, Ph.D., promoted to chief scientific officer -- Vivek Kadambi, Ph.D., joins Recludix as senior vice president of non-clinical sciences and CMC -- Kristin Polsenski, M.B.A., expands role to include chief of staff to the CEO SAN DIEGO, July 14 …
INSPIRED Launches New Social Media Platform that Brings Together Innovators, Investors and Collaborators to Fuel Purpose-Driven Ideas
GlobeNewswire
·
July 14, 2025
ZÜRICH, Switzerland, July 14, 2025 (GLOBE NEWSWIRE) -- INSPIRED today announces the launch of its new social media platform where innovators, investors and collaborators can connect to turn world-changing ideas into reality. By empowering purpose-driven …
JenaValve Announces First Patient Enrolled in ARTIST Randomized Controlled Trial (RCT) Evaluating the Trilogy™ System in Aortic Regurgitation (AR)
GlobeNewswire
·
July 14, 2025
IRVINE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that patient enrollment has begun in the ARTIST study, an RCT evaluating the …
LyondellBasell improves CDP climate score to A in 2024, strengthening ESG leadership
GlobeNewswire
·
July 14, 2025
HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB) today announced it has improved its climate change score from A-minus to A in CDP’s 2024 assessment, placing the company in the leadership category for the second consecutive year. CDP …
Applied Digital Sets Fiscal Fourth Quarter and Full Year 2025 Conference Call for Wednesday, July 30, 2025, at 5:00 p.m. Eastern Time
GlobeNewswire
·
July 14, 2025
DALLAS, July 14, 2025 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance Computing (HPC) …
Health Canada Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)
GlobeNewswire
·
July 14, 2025
TORONTO, July 14, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialisation of novel therapies for rare and ultra-rare genetic diseases, today announced that Health …
Santé Canada étend l’approbation d’Evkeeza® (évinacumab) chez les enfants âgés d’à peine 6 mois atteints d’hypercholestérolémie familiale homozygote (HFHo)
GlobeNewswire
·
July 14, 2025
TORONTO, 14 juill. 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ : RARE), une société biopharmaceutique spécialisée dans la mise au point et la commercialisation de nouveaux traitements contre des maladies génétiques rares et très rares, …
Rumble Names Ian O’Donnell VP for Rumble Cloud
GlobeNewswire
·
July 14, 2025
LONGBOAT KEY, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today announced the hiring of Ian O’Donnell, a 20-year veteran of technology sales and marketing, as the company’s Vice …
Study: First Brain Fitness Tracker Validated for Aging Independently
GlobeNewswire
·
July 14, 2025
SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- A new study shows that a novel online assessment (here) provides a valid scientific measure of the cognitive abilities of older adults related to living independently. The self-administered assessment can be …
Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive
GlobeNewswire
·
July 14, 2025
SAN DIEGO, July 14, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, today announced positive interim safety and efficacy results …
Phunware Announces Updates to Senior Leadership Team
GlobeNewswire
·
July 14, 2025
Jeremy Krol Appointed as Interim Chief Executive Officer and Rahul Mewawalla Appointed as Executive Chairman and Chief AI Architect AUSTIN, Texas, July 14, 2025 (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN) (“Phunware” or the “Company”), today …
ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
GlobeNewswire
·
July 14, 2025
New “Decision to grant” communications in Canada and Israel For the treatment of aggression and social withdrawal MADRID and CAMBRIDGE, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage …
MEXQuick Unveils Mystery Box Campaign Featuring $50,000 Cash Prizes, Apple Products, and $100,000 Weekly Prize Pool
GlobeNewswire
·
July 14, 2025
New York, USA, July 14, 2025 (GLOBE NEWSWIRE) -- MEXQuick, the innovative global trading platform renowned for its Rhythm Contracts and transparent pricing model, today announced the launch of its Mystery Box Challenge — an exciting gamified campaign where …
U.S. Crypto Week Sends Positive Signals: XY Miner Launches XRP Contract Plan to Capture the Next Wave of Growth
GlobeNewswire
·
July 14, 2025
New York City, NY, July 14, 2025 (GLOBE NEWSWIRE) -- In July 2025, the new round of hearings and policy discussions on digital assets in the U.S. Congress was called "Cryptocurrency Week" by the industry, sending a signal of greater openness and support …